Comparison of Antiemetic Effectiveness of Palonosetron Versus Ondansetron in Patients on Cancer Chemotherapy: A Prospective Observational Study in South Indians

Comparison of Antiemetic Effectiveness of Palonosetron Versus Ondansetron in Patients on Cancer Chemotherapy: A Prospective Observational Study in South Indians

Introduction: Chemotherapy Induced Nausea and Vomiting (CINV) is the most distressing side effect of cancer chemotherapy. It can seriously produce an impact on patient's quality of life. Prevention of CINV is far more effective than treatment of an established CINV. If the patient receives...

Full description

Bibliographic Details
Main Authors:	Abdul Aslam Parathoduvil, Asha Sisupalan, Padanayil Lekshmikutty Rema
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2017-05-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	antiemetic prophylaxis chemotherapy induced nausea and vomiting 5ht3 receptor antagonists
Online Access:	https://jcdr.net/articles/PDF/9818/25129_CE[Ra]_F(Sh)_PF1(SY_SS)_PFA(P_SY).pdf

Similar Items

An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy
by: Chepsy C-Philip, et al.
Published: (2015-10-01)

Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study
by: Vazin A, et al.
Published: (2017-09-01)

Comparative Study of an Ondansetron and a Ramosetron an Aprepitant in the Control of Nausea and Vomiting in Gynecologinc Cancer Patient with Chemotherapy
by: HANGGOO Yun, et al.
Published: (2013-12-01)

An overview of the latest ASCO recommendations about antiemetic prophylaxis for treatment-related nausea and vomiting
by: Mehmet Akif Öztürk
Published: (2017-12-01)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
by: May MB, et al.
Published: (2016-05-01)

Palonosetron versus ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic cholecystectomy: a non-inferiority randomized controlled trial
by: Francisco Jos.. Chiaradia Davolos, et al.
Published: (2024-01-01)

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk
by: Mototsugu Shimokawa, et al.
Published: (2021-10-01)

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Cabanillas Stanchi KM, et al.
Published: (2020-09-01)

Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
by: Prasan R Bhandari
Published: (2012-01-01)

Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies
by: Cabanillas Stanchi KM, et al.
Published: (2019-09-01)

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
by: Ghufran salah ahmed, et al.
Published: (2023-05-01)

Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section — a randomized control trial
by: Sylvanus Kampo, et al.
Published: (2019-09-01)

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
by: Affronti ML, et al.
Published: (2016-12-01)

Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study
by: Sung-Hoon Kim, et al.
Published: (2013-06-01)

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment
by: Janet Hardy, et al.
Published: (2018-05-01)

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (house musk shrew)
by: John A Rudd, et al.
Published: (2016-08-01)

Role of Prophylactic Dimenhydrinate Versus Ondansetron as an Adjunct to Dexamethasone on Post-Operative Nausea and Vomiting in Laparoscopic Abdominal Procedures
by: Aaifa Khalid Niazi, et al.
Published: (2020-12-01)

Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial
by: Guilherme Oliveira Campos, et al.
Published: (2019-08-01)

Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review
by: Murad Elias, et al.
Published: (2023-10-01)

The effect of intraoperative antiemetics on postoperative nausea and vomiting in patients receiving intrathecal morphine for elective caesarean deliveries
by: Marcelo Epsztein Kanczuk, et al.
Published: (2022-02-01)

Retrospective analysis of real‐world prescribing data for managing cisplatin‐based chemotherapy‐induced nausea and vomiting in China
by: Xia Si, et al.
Published: (2024-03-01)

Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends
by: Kush Gupta, et al.
Published: (2021-01-01)

Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
by: Soumya Simhadri, et al.

Construction and effectiveness of vomit-free ward
by: Yao Zhi-Qi, et al.
Published: (2019-11-01)

The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial
by: Xiao Li, et al.
Published: (2024-04-01)

The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients
by: Fanming Kong, et al.
Published: (2022-07-01)

Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas
by: Yuta Hori, et al.
Published: (2018-01-01)

Erratum: The clinical observation of acupuncture combined with antiemetic drugs in the prevention and treatment of CINV in breast cancer patients
by: Frontiers Production Office
Published: (2022-10-01)

Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting among children receiving moderate or highly emetogenic chemotherapy
by: Rohan Bansal, et al.
Published: (2023-09-01)

Cost-effectiveness and efficacy of combined dexamethasone–metoclopramide versus ondansetron in the prevention of postoperative nausea and vomiting in women undergoing myomectomy under spinal anesthesia
by: T A Ogbo, et al.
Published: (2019-01-01)

Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice
by: Giulia Notini, et al.
Published: (2024-03-01)

Effect of Adding Midazolam to Dual Prophylaxis for Preventing Postoperative Nausea and Vomiting
by: Jiyoung Lee, et al.
Published: (2021-10-01)

Comparative efficacy of different classes of antiemetic medications for the prevention of nausea and vomiting in cesarean section: A network meta-analysis
by: Zoleykha Asgarlou, et al.
Published: (2023-01-01)

Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region
by: Takayuki Ide, et al.
Published: (2023-06-01)

Influence of ABCB1 genetic polymorphisms on the antiemetic response to ondansetron-based medication for cisplatin-based chemotherapy in South Indian cancer patients in a tertiary care hospital
by: Porkodi Ayyar, et al.
Published: (2023-09-01)

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children
by: So Rae Lee, et al.
Published: (2020-09-01)

5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
by: Reiko Matsui, et al.
Published: (2020-10-01)

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting
by: Jin Y, et al.
Published: (2021-09-01)

Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial
by: Der Sheng Sun, et al.
Published: (2023-05-01)

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
by: Hisanori Shimizu, et al.
Published: (2018-12-01)